Cancer Waiting Times. 1 April Adjuvant Radical External Beam Radiotherapy Definitions. Version 1.0
|
|
- Shonda Adams
- 6 years ago
- Views:
Transcription
1 Cancer Waiting Times Adjuvant Radical External Beam Radiotherapy Definitions Version April 2015
2 Document Control Document Purpose Definitions for NHS Boards for the adjuvant radical external beam radiotherapy data submission for as part of the cancer waiting times extending tumours rolling programme Title Cancer Waiting Times Adjuvant Radical External Beam Radiotherapy Definitions Author Information Services Division of NHS National Services Scotland Issue date 01 April 2015 Issue Version 1.0 Audience Circulation List Superseded Documents Regional Radiotherapy Centres and Scottish Government Policy Leads Regional Radiotherapy Centres Updates from previous version 0.1 KH first draft 0.2 AMcK submission information 0.3 Updates after meeting 17/03/ Comments from IB: Cancer Type simplify ECAD update Prostate scenario 0.5 Comments from ST: Patient cancels adjustment change adjustment 1.0 Introduction updated. Numbering in section 4 corrected. Text or nominated deputy added to Sign Off. Draft removed
3 Contents Page 1 Introduction Data Collection What data is to be submitted? Who is responsible for collating and submitting the data? When and how should the data be reported? Data Validation Who is responsible for the accuracy and sign off of the data? Submission Patient Identifier Cancer Type Date of Previous Intervention/First Intervention Identifier Radical/Palliative Identifier Earliest Clinically Appropriate Date (ECAD) Date of First Adjuvant Radical External Beam Radiotherapy Treatment Waiting Times Adjustment Waiting Times Adjustment Number of Days Waiting Times Adjustment Main Reason Adjusted Waiting Times Scenarios Patient Did Not Attend Patient Cancelled Patient Defers Temporary Co-morbidity Other Patient-Induced Suspension Medical Suspension No Adjustment Change of Medical Plan Waiting Time from ECAD to Start of Treatment Comments
4 1 Introduction The extending tumours work is a rolling programme of short term audits of waiting time performance for individual tumours. The management information produced by NHS Boards is used to inform pathway improvement work. There is an increasing appetite within NHS Boards and the Scottish Government for scrutiny on waiting times for subsequent treatments and it was agreed by the ISD hosted Data and Definitions group that waits for subsequent adjuvant radical external beam radiotherapy should be the focus of the extending tumour work for It is anticipated that by carrying out this snapshot work there will be a better understanding of the intelligence already within the system, the resources that are required to collect and monitor subsequent treatments, and will provide reassurances that Centres/Boards have good clinical governance procedures in place to ensure patients receive their treatment timeously. 2 Data Collection 2.1 What data is to be submitted? Cancer waiting time data on adjuvant radical external beam radiotherapy (excluding first interventions, palliative treatments and treatments for secondaries and recurrences). 2.2 Who is responsible for collating and submitting the data? Of the five radiotherapy treatment centres, Edinburgh, Glasgow, Aberdeen, Dundee and Inverness it is the Board of first adjuvant radical external beam radiotherapy treatment who is responsible for collating and submitting the data to ISD. 2.3 When and how should the data be reported? The data should be submitted to ISD in an excel file including the data items listed in section 4. No patient identifiable information should be included in the file, eg. CHI, name, date of birth. ISD information governance team have advised that ISD can collect this new information for the purpose of this audit without having to seek permission from the ISD Caldicott Guardian since the information will not include patient identifiable information. If we were to collect patient identifiable information we would need to seek permission from ISD Caldicott Guardian first and go through a privacy impact assessment process. Data is to be collected for quarter 2 (April to June) in 2015 and 2016 for comparison. Information on patients who started treatment during the quarter should be submitted to ISD (except for Tayside). Tayside are only able to provide referrals during a time period, therefore Tayside will provide referrals during (time period to be agreed) to allow ISD to select out patients who started treatment in Q2. Information for Q should be submitted to ISD by Friday 25 September Information for Q should be submitted to ISD by Friday 23 September
5 Information should be submitted to Any data or submission queries should also be sent to this address. 3 Data Validation 3.1 Who is responsible for the accuracy and sign off of the data? The data should be signed off by NHS Board Chief Executives or waiting times executive leads (or their nominated deputy) before it is submitted to ISD. ISD will carry out sense checks on the data before analysis is carried out and will liaise with Boards on any queries. It is important the unique patient identifier (pseudoanonymised) is included in the data so ISD can use this to highlight any queries to Boards
6 4 Submission For each patient the following data needs to be submitted: Field Format Mandatory 5 Patient identifier No set format Yes 6 Cancer type 5 characters Yes 7 Date of previous intervention / first intervention identifier No set format Yes - If first treatments are included in the data submission. 8 Radical / palliative identifier No set format Yes if data other than radical is included 9 Earliest Clinically Appropriate Date DDMMYYYY Yes (ECAD) 10 Date of First Adjuvant Radical DDMMYYYY Yes External Beam Radiotherapy Treatment 11.1 Waiting times adjustment number of days (days) Number Yes if waiting time is over 31 days 11.2 Waiting times adjustment main reason 2 characters Yes if waiting time is over 31 days 12 Waiting times from ECAD to start of Number No treatment (days) 13 Comments field Text Yes if waiting time is over 31 days - 6 -
7 5 Patient Identifier Format: No format specified Priority: Mandatory Pseudoanonymised patient identifier to allow ISD to identify any issues or queries with the Boards. 6 Cancer Type Format: 5 characters Priority: Mandatory Include the ICD10 code in the data submission to allow ISD to select on the required codes. For information: Management Information will be monitored on the following cancer types: Breast Cervical Colorectal Head & Neck Lung Lymphoma Melanoma Ovarian Upper Gastro-Intestinal (hepato-pancreato-biliary (HPB) and oesophago-gastric (OG)) Urological (prostate, bladder, other) Management Information will not be monitored on the following cancer types: Sarcomas Mesothelioma Carcinoma in situ tumours (with the exception that patients diagnosed with breast cancer should be included) Carcinoid tumours also known as (neuro-) endocrine tumours Patients where the origin of the primary tumour cannot be determined Recurrent cancer Metastatic cancers (except melanoma where the origin of the primary lesion has never been identified) Other non-invasive tumours e.g. pta tumours All other tumour types not identified above - 7 -
8 7 Date of Previous Intervention/First Intervention Identifier Format: No format specified Priority: Conditional This is to allow ISD to identify first interventions if first interventions are included in the data submission. 8 Radical/Palliative Identifier Format: No format specified Priority: Conditional This is to allow ISD to identify radical interventions if interventions other to radical are included in the data submission. 9 Earliest Clinically Appropriate Date (ECAD) Format: DDMMYYYY Priority: Mandatory Earliest clinically appropriate date is the date that the patient is ready for radiotherapy as stated on the radiotherapy booking form or radiotherapy referral form. Once recorded the ECAD is never adjusted and no adjustments will be included in ECAD if known at that time e.g. if known that a patient is ready clinically to start radiotherapy treatment but has a holiday planned the period of unavailability due to the holiday will not be accounted for in the ECAD but with the appropriate waiting time adjustment. Prostate Cancer: Where a patient requires seed implantation there is a recognised recovery time required. This recovery time will be included in the ECAD as it is the date that the patient is clinically ready for radiotherapy and the patient will not be clinically ready during this recovery time. If the seed implantation is carried out later than planned for and the recovery time is then outwith the time allocated within the ECAD a waiting time adjustment may be applied if this affects the planned delivery date of treatment. Note: For Glasgow it is slightly different in that the two week seed implantation recovery is not factored into the ECAD and a waiting time adjustment is applied for the recovery period. 10 Date of First Adjuvant Radical External Beam Radiotherapy Treatment Format: DDMMYYYY Priority: Mandatory This is the date of the first fraction of adjuvant radical external beam radiotherapy (excluding first interventions, palliative treatments and treatments for secondaries and recurrences)
9 11 Waiting Times Adjustment On reflection of a whole patient pathway there may be some areas of delay not attributable to Board performance. These pathways may be adjusted to discount periods of patient unavailability, for patient-induced delays and medical suspensions. It is recognised that these adjustments can be complex to record and quality assure, however consultation for first treatments showed that it is the right thing to do for measuring performance on waiting times for cancer patients, and aligns to wider waiting times principles and measurement across NHS Scotland. Consultation also concluded that there cannot be a maximum length of adjustment or maximum number of adjustments allowed. As such, a record should be taken of all adjustments in the pathway, and on completion of the pathway all adjustments added together for submission Waiting Times Adjustment Number of Days Format: Number Priority: Mandatory This is the cumulative number of days by which the waiting times pathway has been adjusted. This can equal 0. Note: Glasgow record days expressed as weeks. 0-3 days is recorded as 0 days and 4-7 days is recorded as 1 week Waiting Times Adjustment Main Reason Format: 2 characters Priority: Mandatory The main reason for the number of days adjustment is the one that contributed the longest delay, or if two are equal, the first delay that occurred. Code Description 01 Patient did not attend 02 Patient cancelled 03 Patient defers 04 Temporary co-morbidity 05 Other patient-induced suspension 06 Medical suspension 07 No adjustment 08 Change of medical plan - 9 -
10 11.3 Adjusted Waiting Times Scenarios In this section appointment should be taken to mean any pathway step, e.g. referral, ECAD, clinic, test, treatment. Waiting list should be taken to mean the wait to any pathway step Patient Did Not Attend If a patient does not attend an appointment a waiting times adjustment can be applied. Adjustment is from DNAd appointment to the next step in the pathway. Previous step in the pathway DNA appointment Attended appointment Patient pathway Adjustment Patient does not attend Scenario 1 Patient does not attend an appointment on the 2 June and has an appointment rescheduled for 22 June.. Answer Adjustment is from the date the patient did not attend to the next step in the pathway. This can be calculated in 2 different ways: Unavailability calculation Unavailability is from 2 June to 21 June (inclusive) making it a WTA of 20 days. Or shown as: June 2010 M T W T F S S = 20 days Dates calculation Using the appointment dates this would be 22 June minus 02 June giving a WTA of 20 days
11 Patient Cancelled A patient may have to cancel a booked appointment (this included patients who attend but could not wait). Adjustment is from the date of the cancelled appointment to the next step in the pathway. Previous step in the pathway Patient cancels appointment Original appointment New appointment Patient pathway Adjustment Patient Defers Patients may choose to defer the next appointment until after a holiday or until they can make arrangements for other commitments. Adjustment is the length of unavailability. Previous step in the pathway Patient unavailable Patient available Attended appointment Patient pathway Adjustment Patient Defers Scenario
12 Patient has ECAD of 18 November. Whilst making an appointment to start treatment the patient advises they will be unavailable from 30 November till 15 December. An appointment is made on 18 December. Answer Adjustment is the length of unavailability. This can be calculated in 2 ways: Unavailability calculation Unavailability is from 30 November to 15 December (inclusive) making it a WTA of 16 days. Or shown as: December 2010 M T W T F S S = 16 days Dates calculation This would be 16 December minus 30 November giving a WTA of 16 days
13 Temporary Co-morbidity The patient has or develops an illness or condition that makes the patient unfit to attend for an appointment, e.g. viral infection, neutropaenia, exacerbation of a chronic or pre-existing condition like lung disease or hypertension. Adjustment is from the date the patient is not fit to attend the appointment to the date the patient is fit to attend the appointment. Patient now fit to attend appointment Previous step in the pathway Patient unfit/ cancels/dnas original appointment New appointment Patient pathway Adjustment Temporary co-morbidity scenario A patient phones on 5 May to advise they are too ill to attend an appointment made for the 28 May and cancels. The patient advises they should be well enough by the 2 June and a new appointment is made for 4 June. Answer Adjustment is from the date the patient is unfit to attend the appointment to the date the patient is fit. It can be calculated in 2 different ways: Unavailability calculation Unavailability is from 5 May to 1 June (inclusive) making it a WTA of 28 days. Or shown as: May 2010 M T W T F S S = 28 days Dates calculation Using the appointment dates this would be 1 June minus 4 May giving a WTA of 28 days
14 Other Patient-Induced Suspension Occasionally a patient may require a repeat appointment in their pathway, because they choose to take some time to think over their options, or because they did not follow pre-appointment instructions such as stopping a medication (e.g metformin). Adjustment is from the first appointment to the repeat appointment. Previous step in the pathway Appointment Repeat appointment Patient pathway Adjustment Other patient-induced suspension Scenario Patient at previous appointment (15 July) with clinician was instructed to stop taking their medication 5 days before having an investigation (1 August). On day of appointment patient advised that they forgot to stop their medication. Another appointment was made on 15 August. Answer Adjustment is from the first appointment to the repeat appointment. It can be calculated in 2 different ways: Unavailability calculation Unavailability is from 1 August to 14 August (inclusive) making it a WTA of 14 days. Or shown as: August 2010 M T W T F S S = 14 days Dates calculation Using the appointment dates this would be 15 August minus 1 August giving a WTA of 14 days
15 06 - Medical Suspension Medical suspension should be used when an additional and necessary pre-treatment step is required, or when a step in the pathway has to be delayed because an unacceptable risk would be incurred if that step were to take place within a fixed time period. For example, recovery from surgery, chemotherapy, dental clearance or physiotherapy. Adjustment is from the date the patient is not fit to attend the appointment to the date the patient is fit to attend the appointment. Criteria met for patient to be fit to continue Medical decision patient not fit for next step Appointment Patient pathway Adjustment No Adjustment Problems resulting from hospital operational circumstances should not result in any detriment to the patient; for example, the cancellation of a clinic at short notice, appointments being cancelled or moved by the hospital, Consultants annual leave, referral delay, simulator breakdown or plan not volumed or checked in time. Therefore, waiting times adjustments cannot be made in these situations Change of Medical Plan Where a patient is initially referred for one type of radiotherapy treatment which is booked but it then becomes apparent that a different radiotherapy treatment is required which requires a different booking and planning. Or where a patient is initially referred for a radiotherapy treatment that does not require an inpatient bed so it is not planned for but it becomes apparent that the patient does require a treatment that needs an inpatient bed and this has not been planned for. Adjustment equals the number of days that the starting date has to be delayed from the date the patient could have started treatment
16 12 Waiting Time from ECAD to Start of Treatment Format: Number Priority: Optional This is the number of days from ECAD to Date of First Adjuvant Radical External Beam Radiotherapy Treatment less the cumulative number of days by which the waiting times pathway has been adjusted. Note: Glasgow record days expressed as weeks. 0-3 days is recorded as 0 days and 4-7 days is recorded as 1 week. 13 Comments Format: Text Priority: Conditional Comments field is to record any additional information where waiting time is over 31 days
Project Brief. New Cancer Waiting Times. Data Quality Assurance Audit
Project Brief New Cancer Waiting Times Data Quality Assurance Audit Version 1.0 Contents 1 Introduction...3 2 Data Recording and Submitting...4 3 Data Quality Assurance Audit...4 3.1 Areas of Investigation:...4
More informationBetter Cancer Care, An Action Plan. Cancer Waiting Times Standards Data & Definitions Manual Version April 2012
Better Cancer Care, An Action Plan Cancer Waiting Times Standards Data & Definitions Manual Version 4.1 1 April 2012-1 - Document Purpose Definitions Manual for NHS Boards for the cancer waiting times
More informationData & Definitions Frequently Asked Questions
Cancer Waiting Times Data & Definitions Frequently sked uestions This document provides questions and answers on data and definitions for Cancer Waiting Times. The references below provide context and
More informationBetter Cancer Care, An Action Plan. Cancer Waiting Times Standards Data & Definitions Manual Version January 2017
Better Cancer Care, An Action Plan Cancer Waiting Times Standards Data & Definitions Manual Version 4.5 1 January 2017 Document Purpose Definitions Manual for NHS Boards for the cancer waiting times standards
More informationCancer Waiting Times in NHSScotland
Cancer Waiting Times in NHSScotland 1 October to 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics
More informationCancer Waiting Times in NHSScotland
Publication Report Cancer Waiting Times in NHSScotland 1 April to 30 June 2017 Publication date 26 September 2017 A National Statistics Publication for Scotland Contents Introduction... 3 Main points...
More informationCancer Waiting Times in NHSScotland
Publication Report Cancer Waiting Times in NHSScotland 1 July to 30 September 2017 Publication date 12 December 2017 A National Statistics Publication for Scotland Contents Introduction... 3 Main points...
More informationConsultation on publication of new cancer waiting times statistics Summary Feedback Report
Consultation on publication of new cancer waiting times statistics Summary Feedback Report Information Services Division (ISD) NHS National Services Scotland March 2010 An electronic version of this document
More informationScottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit
Scottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit National Cancer Clinical Audit: Baseline Survey Report (May 09) Purpose: The purpose of this paper is to provide
More informationCancer Outcomes and Services Dataset: Implications for clinical teams
Cancer Outcomes and Services Dataset: Implications for clinical teams Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Consultant & Senior Lecturer in Respiratory Medicine,
More informationNational Drug and Alcohol Treatment Waiting Times
National Drug and Alcohol Treatment Waiting Times 1 October 31 December 2017 Publication date 27 March 2018 A National Statistics publication for Scotland This is a National Statistics Publication National
More informationCancer Waiting Times in NHSScotland
Cancer Waiting Times in NHSScotland 1 October to 31 December 2018 Publication date 26 March 2019 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics
More informationNational Drug and Alcohol Treatment Waiting Times Report
Publication Report National Drug and Alcohol Treatment Waiting Times Report October December 2016 Publication Date 28 March 2017 A National Statistics Publication for Scotland Contents Introduction...
More informationRe-audit of Radiotherapy Waiting Times 2005
Abstract Re-audit of Radiotherapy Waiting Times 2005 E. Summers, M Williams Royal College of Radiologists, 38 Portland Place, London W1B 4JQ, UK Aim: To determine current waiting times for radiotherapy
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationNational Drug and Alcohol Treatment Waiting Times Report
Publication Report National Drug and Alcohol Treatment Waiting Times Report October December 2011 27 March 2012 A National Statistics Publication for Scotland Contents Contents... 1 About ISD... 2 Official
More informationRe-audit of Radiotherapy Waiting Times in the United Kingdom, 2007
Re-audit of Radiotherapy Waiting Times in the United Kingdom, 2007 K. J. Drinkwater, M. V. Williams The Royal College of Radiologists, 38 Portland Place, London W1B 1JQ, UK ABSTRACT: This is the fourth
More informationRestorative dentistry new patient clinic
Restorative dentistry new patient clinic You have been referred to the Restorative Dentistry Service for an assessment regarding a specific dental problem, and this leaflet provides information about your
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationAbdominal Aortic Aneurysm (AAA) Screening. Date: 7 March 2017 Version: 1.0
Information Services Division/ National Specialist and Screening Services Directorate Abdominal Aortic Aneurysm (AAA) Screening Guidance and information on the key performance indicators (KPIs) for the
More informationCancer Outcomes and Services Dataset. What is COSD? Skin Cancers Workshop October 2012
Cancer Outcomes and Services Dataset What is COSD? Skin Cancers Workshop October 2012 17 years ago......cancer registration and careful monitoring of treatment and outcomes are essential... Calman-Hine
More informationNational Drug and Alcohol Treatment Waiting Times
National Drug and Alcohol Treatment Waiting Times 1 April 30 June 2018 Publication date 25 September 2018 A National Statistics publication for Scotland This is a National Statistics Publication National
More informationFaster Cancer Treatment Indicators: Use cases
Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:
More informationCANCER OPERATIONAL POLICY
CANCER OPERATIONAL POLICY Document Author Written By: Lead Cancer Nurse/Peer Review and Administration Manager Date: October 2016 Authorised Authorised By: Chief Executive Date: 8 th vember 2016 Lead Director:
More informationAudit Report. Breast Cancer Quality Performance Indicators. Patients diagnosed during Published: February 2018
Breast Cancer Managed Clinical Network Audit Report Breast Cancer Quality Performance Indicators Patients diagnosed during 2016 Published: February 2018 Mr Douglas Brown NOSCAN Breast Cancer MCN Clinical
More informationNOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)
Item 18-13c NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May 2013 BREAST CANCER MCN: Breast Disease: Breast Document ready to circulate lead to be discussed
More informationIVF Waiting Times Publication
IVF Waiting Times Publication Quarter ending 30 September 2018 Publication date 27 November 2018 An Official Statistics publication for Scotland This is an Official Statistics Publication The Official
More informationSelective Dorsal Rhizotomy (SDR) Scotland Service Pathway
Selective Dorsal Rhizotomy (SDR) Scotland Service Pathway This pathway should to be read in conjunction with the attached notes. The number in each text box refers to the note that relates to the specific
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks Sarcoma National Managed Clinical Network Activity Report April 2013 March 2014 Dr Jeff White Consultant Oncologist NMCN Clinical Lead Lindsay Campbell
More informationUROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT UROLOGICAL CANCER 2010 COMPARATIVE AUDIT REPORT Dr Prasad Bollina, NHS Lothian SCAN Lead Urology Cancer Clinician Dr Prasad Bollina, NHS Lothian
More informationNorth of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network
North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network Introduction Cancer Incidence & Projected Trends National ISD reported that
More informationUnited Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report
United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report 20 June 2018 UKIACR Performance Indicators 2018 report 1 Contents Introduction... 3 Commentary for
More informationSCAN Skin Group Friday 1 st November 2013
SCAN Skin Group Friday 1 st November 2013 Dermatology Seminar Room, Lauriston Buildings with videolinks to Oncology Seminar Room, Western General Hospital and Borders General Hospital. MINUTES Present
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationMeeting : North of Scotland Regional Cancer Advisory Forum Time: pm Date: Wednesday 2 nd July 2014
Item Meeting : North of Scotland Regional Cancer Advisory Forum Time: 2.00-4.00pm Date: Wednesday 2 nd July 2014 Host Venue: Foresterhill House Committee Room, ARI site + V/C: Ante room, Assynt House,
More informationActivity Report April June 2012
Urological Cancers Managed Clinical Network Activity Report April 2011- June 2012 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationAudit Report. Bladder Cancer Quality Performance Indicators. Patients diagnosed April 2015 March Published: May 2017
Urological Cancer Managed Clinical Network NORTH OF SCOTLAND PLANNING GROUP Audit Report Bladder Cancer Quality Performance Indicators Patients diagnosed April 2015 March 2016 Published: May 2017 Mr Sarfraz
More informationActivity Report April 2012 March 2013
Colorectal Cancer Managed Clinical Network Activity Report April 2012 March 2013 Paul Horgan Professor of Surgery MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationRTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
More informationReferral to treatment consultant-led waiting times
Referral to treatment consultant-led waiting times How to Measure DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development Finance
More informationWednesday 29 July Management of Pandemic Flu
JOINT TRUST BOARD AND MEMBERSHIP COUNCIL MEETING TITLE Wednesday 29 July 2009 Management of Pandemic Flu PURPOSE To provide a briefing and assurance to the Trust Board and Governors on the actions taken
More informationWaiting Times for Suspected and Diagnosed Cancer Patients
Waiting Times for Suspected and Diagnosed Cancer Patients 2015-16 Annual Report Waiting Times for Suspected and Diagnosed Cancer Patients 1 Waiting Times for Suspected and Diagnosed Cancer Patients Prepared
More information2010 National Survey. East Kent Hospitals University NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. The North West London Hospitals NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. Royal National Orthopaedic Hospital NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. The Leeds Teaching Hospitals NHS Trust
National Cancer Patient Experience Programme 2010 National Survey Published January 2011 The National Cancer Patient Experience Survey Programme is being undertaken by Quality Health on behalf of the Department
More information2010 National Survey. University College London Hospitals NHS Foundation Trust
National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme
More informationKEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change?
SCOTTISH GOVERNMENT: NEXT MENTAL HEALTH STRATEGY Background The current Mental Health Strategy covers the period 2012 to 2015. We are working on the development of the next strategy for Mental Health.
More information2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust
National Cancer Patient Experience Programme 2010 National Survey Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme
More informationOESOPHAGO-GASTRIC CANCER 2016
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT OESOPHAGO-GASTRIC CANCER 2016 COMPARATIVE AUDIT REPORT Mr Peter Lamb SCAN Lead Upper GI Cancer Clinician Dr Jonathan Fletcher, Consultant Physician,
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationCANCER WAITING TIMES (CWTs) A GUIDE (VERSION 8.0)
CANCER WAITING TIMES (CWTs) A GUIDE (VERSION 8.0) This document is to be used to support the monitoring and management of cancer waiting times from 01 July 2012 supporting the implementation of [insert
More informationAudit Report. Endometrial Cancer Quality Performance Indicators. Patients diagnosed October 2014 September Published: September 2016
Gynaecology Managed Clinical Network NORTH OF SCOTLAND PLANNING GROUP Audit Report Endometrial Cancer Quality Performance Indicators Patients diagnosed October 2014 September 2015 Published: September
More informationDeveloped by Marion Wood and Children s Dental Needs Steering Group
Title Document Type Issue no DNA Policy Policy Clinical Governance Support Team Use Issue date 30.05.13 Review date 30.05.15 Distribution Prepared by Dental Staff Marion Wood Developed by Marion Wood and
More informationActivity Report April 2014 March 2015
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2014 March 2015 Dr Avinash Kanodia Consultant Radiologist
More informationCANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups
CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups Introduction/Background 1. Our National Health: A Plan for action, a plan for
More informationNational Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)
National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health
More informationAnnual Report April 2016 March 2017
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Annual Report April 2016 March 2017 Professor Stephen Wigmore Consultant Surgeon
More informationNational Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results University Hospitals of Leicester NHS Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is undertaken
More informationNational Group for Volunteering in NHS Scotland
National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 23 August 2016 at Delta House, West Nile Street, Glasgow Present Neil Galbraith Rob Coward Sandie Dickson Marion Findlay
More informationNational Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results East Kent Hospitals University NHS Foundation Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is
More informationActivity Report March 2012 February 2013
Lung Cancer Managed Clinical Network Activity Report March 2012 February 2013 John McPhelim Lead Lung Cancer Nurse MCN Clinical Lead Kevin Campbell Network Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationActivity Report July 2014 June 2015
Urological Cancers Managed Clinical Network Activity Report July 2014 June 2015 Mr Gren Oades Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 5
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationScottish Bowel Screening Programme Statistics
Publication Report Scottish Bowel Screening Programme Statistics For invitations between 1 November 2010 and 31 October 2012 Publication date 27 August 2013 A National Statistics Publication for Scotland
More informationAudit Report. Cervical Cancer Quality Performance Indicators. Patients diagnosed October 2014 September Published: September 2016
Gynaecology Managed Clinical Network NORTH OF SCOTLAND PLANNING GROUP Audit Report Cervical Cancer Quality Performance Indicators Patients diagnosed October 2014 September 2015 Published: September 2016
More informationAccess to Male & Female Sterilisation
Access to Male & Female Sterilisation The number of female sterilisation procedures and male vasectomies performed by each NHS board per women and men of reproductive age and the waiting times for these
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationCathy Geddes: Chief Executive Officer Matt Riddleston: Trust Lead Macmillan Cancer Nurse Simon Smith: Trust Cancer Lead Clinician
Cancer Access and Operational Policy Policy Register No: 09124 Status: Public Developed in response to: CWT Version 9 Going Further on Cancer Waits Achieving World Class Cancer Outcomes A strategy for
More informationTrust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE
NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog
More informationWales Cancer Patient Experience. Survey Aneurin Bevan University Health Board. Published January 2014
Wales Cancer Patient Experience Survey 2013 Aneurin Bevan University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government
More informationabcdefghijklmnopqrstu
CMO and Public Health Directorate Health Improvement Strategy Division Dear Colleague Scottish Abdominal Aortic Aneurysm Screening Programme This CEL outlines the plan for the implementation of the AAA
More informationUROLOGY CANCER 2009 COMPARATIVE AUDIT REPORT
Urological Cancer Audit 2009 SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT UROLOGY CANCER 2009 COMPARATIVE AUDIT REPORT Dr Prasad Bollina, NHS Lothian SCAN Lead Urology Cancer Clinician Dr
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)
North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016
More informationAudit Report. Breast Cancer Quality Performance Indicators. Patients diagnosed during Published: December 2015 NORTH OF SCOTLAND PLANNING GROUP
NORTH OF SCOTLAND PLANNING GROUP Breast Cancer Managed Clinical Network Audit Report Breast Cancer Quality Performance Indicators Patients diagnosed during Published: December 2015 Mr Douglas Brown NOSCAN
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationData & Definitions Frequently Asked Questions
Cancer Waiting Times Data & Definitions Frequently sked uestions This document provides questions and answers on data and definitions for Cancer Waiting Times. Further information can be found in the Guidance
More informationCommissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013
Commissioning Cancer Services Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013 The Health & Social Care Bill (27 th March 2012) Two New Organisations NHS Commissioning Board (NHS CB)
More informationTesticular Cancer Quality Performance Indicators
Testicular Cancer Quality Performance Indicators Patients diagnosed between October 2014 and September 2017 Publication date 28 August 2018 An Official Statistics publication for Scotland This is an Official
More informationNATIONAL DENTAL INSPECTION PROGRAMME
1. Purpose of Paper NATIONAL DENTAL INSPECTION PROGRAMME This paper describes the main components and processes associated with the National Dental Inspection Programme (NDIP) and demonstrates how the
More informationOvarian Cancer Quality Performance Indicators
Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official
More informationScottish Disorders of Sex Development Clinical Network Executive Group Meeting
National Services Division Area 062 Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Telephone 0131 275 6575 Fax 0131 275 7614 www.nsd.scot.nhs.uk Minutes v1.0 Subject: Author: Date: Location: Scottish
More informationWorking Group on Cancer Services
21 st November 2016 Working Group on Cancer Services A meeting of the Working Group on Cancer Services was held on 3 rd November 2016 at 11am, The Royal College of Pathologists, 4th Floor, 21 Prescot Street,
More informationAbdominal Aortic Aneurysm (AAA) Screening
Abdominal Aortic Aneurysm (AAA) Screening Guidance and information on the Key Performance Indicators (KPIs) for the Abdominal Aortic Aneurysm screening programme 6 March 2018 V1.1 Contents Introduction...
More informationPATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE
PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network
More informationIdentifying and counting people living with treatable but not curable cancer
Identifying and counting people living with treatable but not curable cancer Rachel White Joanna Pethick, Archie Macnair, Gregory Fallica, Jennifer Than and Jane Maher September 2018 Who are the people
More informationSOUTH WEST of SCOTLAND BREAST SCREENING SERVICE
SOUTH WEST of SCOTLAND BREAST SCREENING SERVICE Area covered Ayrshire and Arran and Dumfries and Galloway Population to be invited is 80,161+ over three years (Period:2014/17) The service is located within
More informationWales Cancer Patient Experience Survey Hywel Dda University Health Board. Published January 2014
Wales Cancer Patient Experience Survey 2013 Hywel Dda University Health Published January 2014 The Wales Cancer Patient Experience Survey was undertaken by Quality Health on behalf of the Welsh Government
More informationBreast Screening. Helping you decide
Breast Screening Helping you decide It is up to you if you want to have breast screening or not. This leaflet will help you decide. Why does the NHS offer breast screening? The NHS offers breast screening
More informationMINUTE OF MEETING HELD ON 3 NOVEMBER 2008, ST ANDREW S HOUSE, EDINBURGH
Scottish Government Health Department EMERGENCY ACCESS DELIVERY TEAM MINUTE OF MEETING HELD ON 3 NOVEMBER 2008, ST ANDREW S HOUSE, EDINBURGH Present: Tim Davison (Chair) Kathleen Bessos Dr. Anne Hendry
More informationMammo-50 Eligibility Queries
Mammo-50 Eligibility Queries Are patients who have received either neo-adjuvant or adjuvant chemo, radiotherapy or been part of another trial, ie OPTIMA, FAST FORWARD excluded from entry? Any patients
More informationReferral and pathways for surgically managed Carpal Tunnel Syndrome patients: guidelines and current practice
Referral and pathways for surgically managed Carpal Tunnel Syndrome patients: guidelines and current practice A Report from the Musculoskeletal Audit on behalf of the Scottish Government The information
More informationabcdefghijklmnopqrstu
Chief Medical Officer Directorate Chief Medical Officer and Secretariat Division abcdefghijklmnopqrstu T: 0131-244 2399 F: 0131-244 2989 E: sandra.falconer@scotland.gsi.gov.uk NHS Board Medical and Nursing
More informationNational Cancer Patient Experience Survey Results. Milton Keynes University Hospital NHS Foundation Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results Milton Keynes University Hospital NHS Foundation Trust Published July 2016 The National Cancer Patient Experience Survey is undertaken by Quality
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationSOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT BREAST CANCER 2013 COMPARATIVE AUDIT REPORT Mr Glyn Neades Chair Breast Group and Consultant Surgeon, NHS Fife Mr Matthew Barber, Consultant
More informationCancer Access Policy. Key Points
Trust Policy Cancer Access Policy Key Points The timescales within which cancer patients are treated is a vital quality measure and key indicator of the quality of cancer services offered at the Trust.
More informationCOSD & Source of Referral
COSD & Source of Referral A Brief guide October 2014 Michael Sharpe Data Improvement Manager National Cancer Registration Service What is COSD? Cancer and Outcomes Services Dataset Clinical dataset for
More information